Matthias Holdhoff Selected Research

Matthias Holdhoff Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 04/2010
24	Glioma (Gliomas) 01/2021 - 04/2010
13	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2005
9	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2005
7	Lymphoma (Lymphomas) 10/2021 - 09/2013
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2011
3	Oligodendroglioma 02/2019 - 09/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2005 - 01/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2011
2	Circulating Neoplastic Cells 02/2014 - 07/2013
2	Philadelphia Chromosome 03/2005 - 08/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Disease Progression 01/2021
1	Ependymoma 07/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2020
1	Fever (Fevers) 05/2020
1	Cytopenia 05/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2019
1	Hypertension (High Blood Pressure) 01/2017
1	Bradycardia 01/2017
1	Water Intoxication 01/2017
1	Turcot syndrome 01/2017
1	Inflammation (Inflammations) 09/2016
1	Melanoma (Melanoma, Malignant) 09/2016
1	Diarrhea 09/2016
1	Enterocolitis 09/2016
1	Enteritis 09/2016
1	Acute Kidney Injury (Acute Renal Failure) 09/2016
1	Hypokalemia 09/2016

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2012
7	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2011
5	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 07/2014
4	Immune Checkpoint InhibitorsIBA 01/2021 - 09/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2011
4	Imatinib Mesylate (Gleevec)FDA Link 04/2010 - 01/2002
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 02/2019
3	Rituximab (Mabthera)FDA Link 12/2019 - 07/2014
3	AcidsIBA 10/2017 - 01/2002
3	Phosphotransferases (Kinase)IBA 04/2015 - 03/2005
3	Proteins (Proteins, Gene)FDA Link 04/2015 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
2	SteroidsIBA 09/2016 - 05/2015
2	Cell-Free Nucleic AcidsIBA 08/2015 - 07/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2015 - 02/2015
2	LY-2157299IBA 04/2015 - 02/2015
2	Glial Fibrillary Acidic ProteinIBA 10/2014 - 08/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2010 - 03/2005
2	Tyrosine Kinase InhibitorsIBA 04/2010 - 08/2003
2	Glycoproteins (Glycoprotein)IBA 08/2003 - 01/2002
1	belinostatIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021
1	Calcineurin InhibitorsIBA 10/2021
1	fludarabineIBA 10/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021
1	AnthelminticsIBA 01/2021
1	Mebendazole (Anti-Worm)FDA Link 01/2021
1	pembrolizumabIBA 01/2021
1	CytokinesIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	T-DNAIBA 01/2021
1	ivosidenibIBA 10/2020
1	PyrrolesIBA 05/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Protons (Proton)IBA 01/2019
1	AmidesIBA 01/2019
1	ibrutinibIBA 01/2018
1	AntigensIBA 10/2017
1	pyridineIBA 10/2017
1	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 10/2017
1	Antiviral Agents (Antivirals)IBA 06/2017
1	Formaldehyde (Formol)FDA Link 06/2017
1	ParaffinIBA 06/2017
1	alovudineIBA 03/2017
1	Biological ProductsIBA 03/2017
1	MibefradilIBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016
1	CTLA-4 AntigenIBA 09/2016

Therapy/Procedure

14	Therapeutics 05/2020 - 01/2002
14	Drug Therapy (Chemotherapy) 01/2020 - 06/2007
7	Radiotherapy 01/2022 - 03/2005
2	Aftercare (After-Treatment) 01/2019 - 03/2017
1	Transplantation 10/2021
1	Treatment Delay 01/2021
1	Immunotherapy 07/2020
1	Chemoradiotherapy 07/2020
1	Re-Irradiation 10/2018
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2017
1	PCV regimen 05/2017